Sequestration Kicks In: FDA Will Manage For Now, But Could Suffer Aftereffects
This article was originally published in The Rose Sheet
Executive Summary
With the implementation of across-the-board spending cuts, FDA will be unable to add the hundreds of new employees needed to meet the goals of user-fee and other programs, a paucity that could damage the agency for years to come.